To enhance the clinical utility of chromosomal copy number (CN) data through an interactive tool for improved precision oncology.
Key Findings:
CnQuant achieved a 98.71% concordance rate with accredited routine diagnostic data in an internal validation study of 30 brain tumors.
The tool offers enhanced interactive annotation of focal CNVs and cohort-level CNV frequency analyses.
CnQuant is open-source, low in computational requirements, and highly scalable for clinical implementation.
Interpretation:
CnQuant addresses existing limitations in CNV analysis tools by providing a user-friendly interface and comprehensive genomic annotations, facilitating better clinical decision-making.
Limitations:
The validation study was limited to 30 brain tumor samples, which may not represent all tumor types.
The tool's effectiveness in clinical settings outside of the tested cohorts remains to be fully evaluated.
Conclusion:
CnQuant is poised to significantly enhance precision medicine by providing actionable insights into chromosomal copy number variations, thereby guiding personalized oncologic care decisions.
